Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Alper Sevinc"'
Autor:
Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Metin Ozkan, Guzin Gonullu Demirag, Hasan Senol Coskun, Bulent Karabulut, Turkkan Evrensel, Mehmet Ali Ustaoglu, Feyyaz Ozdemir, Hande Turna, Tugba Yavuzsen, Faruk Aykan, Alper Sevinc, Hakan Akbulut, Deniz Yuce, Mutlu Hayran, Saadettin Kilickap
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered at first-line in a
Externí odkaz:
https://doaj.org/article/1ae3c043ebb54a6c82250c0cb4ea7be9
Autor:
Ali Suner, Hakan Buyukhatipoglu, Ozan Balakan, Mehmet Emin Kalender, Turgay Ulas, Alper Sevinc, Celalettin Camci
Publikováno v:
Case Reports in Oncological Medicine, Vol 2014 (2014)
Gastric cancer is one of most common types of cancers. Metastatic gastric cancer has a poor prognosis and is accepted as incurable at this stage. Treatment of metastatic gastric cancer did not progress substantially until new targeted agents have com
Externí odkaz:
https://doaj.org/article/20b78ac376d44b89b8738e51a3d78ea4
Publikováno v:
Acta Medica, Vol 51, Iss 4, Pp 237-239 (2008)
Primary cardiac angiosarcoma is a rare tumor, and surgical resection is often required to relieve its symptoms. A 54-year-old male with a large primary cardiac angiosarcoma is described in this case report. The tumor was located in the right atrium a
Externí odkaz:
https://doaj.org/article/65316708001d4a3ab8033c431c45b2da
Publikováno v:
Case Reports in Medicine, Vol 2010 (2010)
Radiotherapy and concomitant/adjuvant therapy with temozolomide are a common treatment regimen for children and adults with high-grade glioma. Although temozolomide is generally safe, it can rarely cause life-threatening complications. Here we report
Externí odkaz:
https://doaj.org/article/bf3eb92e8b864eff83a5bbed7de60acb
Autor:
Gurkan Karakas, Alper Sevinc
Publikováno v:
Catalysis Today. 323:159-165
The high temperature catalytic oxidation (HTCO) performance of Al2O3 supported Pt, Cu, Cu-Ce and Fe catalysts were systematically studied with a perspective of selective oxidation of nitrogenous compounds to nitric oxide for quantitative determinatio
Autor:
Lesley Pocock, Abdulrazak Abyad, Mehmet Rami Helvaci, Ali Keskin, Alper Sevinc, Celaletdin Camci
Publikováno v:
Middle East Journal of Nursing. 15
Background: We tried to understand the presence of any atherosclerotic background of cirrhosis in patients with sickle cell diseases (SCDs). Methods: The study was performed in the Hematology Service of the Mustafa Kemal University on SCDs patients b
Autor:
Irfan Cicin, Mehmet Artac, Feyyaz Ozdemir, Metin Ozkan, Mustafa Benekli, Nezih Meydan, Sadettin Kilickap, Alper Sevinc, Abdurrahman Isikdogan, Faysal Dane, Mehmet Aliustaoglu, Berna Oksuzoglu, Mahmut Gumus, Emin Tamer Elkiran, Ozgur Ozyilkan
Objective Cytokines have been the mainstay of treatment in metastatic renal cell cancer (mRCC) for decades before the introduction of tyrosine kinase inhibitors (TKIs), which dramatically changed the therapeutic landscape in these patients. This obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3237934761fbe92e804509ecf1df16b7
https://avesis.erciyes.edu.tr/publication/details/761eac20-9e0e-4edb-92dc-e3cf38ba25d0/oai
https://avesis.erciyes.edu.tr/publication/details/761eac20-9e0e-4edb-92dc-e3cf38ba25d0/oai
Autor:
Feyyaz Ozdemir, Deniz Yuce, Mehmet Ali Ustaoglu, Bulent Karabulut, Hakan Akbulut, Metin Ozkan, Guzin Demirag, Mutlu Hayran, Faysal Dane, Turkkan Evrensel, Tugba Yavuzsen, Berna Oksuzoglu, Abdurrahman Isikdogan, Alper Sevinc, Nuriye Ozdemir, Saadettin Kilickap, Suayib Yalcin, Hande Turna, Faruk Aykan, Hasan Şenol Coşkun
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
BackgroundCombination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered at first-line in advanced pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298c5035da966a6d3fe783ad6985da5f
https://avesis.deu.edu.tr/publication/details/8771facb-b0d2-4216-b76a-f2358ba9881f/oai
https://avesis.deu.edu.tr/publication/details/8771facb-b0d2-4216-b76a-f2358ba9881f/oai
Autor:
Alper Sevinc, Mustafa Benekli, Hasan Şenol Coşkun, Kirhan Ozgurdal, Suayib Yalcin, Metin Ozkan, Turkkan Evrensel, Perran Fulden Yumuk, Nuri Faruk Aykan, Faysal Dane, Ismail Oguz Kara, Ulus Ali Sanli, Idris Yucel
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
BMJ Open
BMJ Open
Objectives Regorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase III trials, but has not been evaluated in Turkey. REGARD evaluated the safety and efficacy
Autor:
Cihan Erol, MehmetAli Nahit Sendur, Irem Bilgetekin, DuyguBayir Garbioglu, Jamshid Hamdard, Sinem Akbas, Mutlu Hizal, Cagatay Arslan, Alper Sevinc, Ahmet Kucukarda, Dilek Erdem, Seda Kahraman, Emre Cakir, Aykut Demirkiran, Sercan On, Izzet Dogan, AtikePinar Erdogan, Sinan Koca, Pinar Kubilay, OrhanOnder Eren, Ebru Cilbir, Emir Celik, Murat Araz, DenizTataroglu Ozyukseler, MahmutEmre Yildirim, Aykut Bahceci, Halil Taskaynatan, Abdilkerim Oyman, GulhanIpek Deniz, Serkan Menekse, Engin Kut, Ahmet Gulmez, Abdullah Sakin, Erdinc Nayir, Ramazan Acar, Erdem Sen, Ali Inal, Serdar Turhal, AliOsman Kaya, Semra Paydas, Didem Tastekin, Ilhan Hacibekiroglu, Irfan Cincin, Ahmet Bilici, NilMolinas Mandel, DidemSener Dede, MuhammedBulent Akinci, Berna Oksuzoglu, Dogan Uncu, Bulent Yalcin, Mehmet Artac
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:347
Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) previously treated with oxaliplatin. We aimed to investigate the effic